ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $867,940 | -36.6% | 633,533 | +12.4% | 0.00% | – |
Q2 2023 | $1,369,947 | -57.9% | 563,764 | -0.1% | 0.00% | – |
Q1 2023 | $3,251,272 | -92.0% | 564,457 | -87.6% | 0.00% | -100.0% |
Q4 2022 | $40,848,398 | +46.7% | 4,569,172 | +133.3% | 0.00% | -50.0% |
Q3 2022 | $27,847,000 | +300.8% | 1,958,265 | +311.5% | 0.00% | – |
Q2 2022 | $6,947,000 | -12.3% | 475,856 | +19.9% | 0.00% | – |
Q1 2022 | $7,923,000 | +38.3% | 396,768 | +21.2% | 0.00% | – |
Q4 2021 | $5,727,000 | +146.5% | 327,441 | +10.5% | 0.00% | – |
Q3 2021 | $2,323,000 | -10.1% | 296,247 | +17.9% | 0.00% | – |
Q2 2021 | $2,585,000 | +1786.9% | 251,197 | +2290.1% | 0.00% | – |
Q1 2021 | $137,000 | -36.9% | 10,510 | -32.0% | 0.00% | – |
Q4 2020 | $217,000 | +17.9% | 15,466 | 0.0% | 0.00% | – |
Q3 2020 | $184,000 | – | 15,466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |